NCT01119924 - A Clinical Study for Assessment of the Efficacy and Safety of Mirtazapine (Smilon) in Depression Patients With Pain | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

August 31, 2010

Study Completion Date

November 30, 2010

Conditions

DepressionPain

Interventions

DRUG

Smilon®

Smilon® tablet 15mg mg/day or placebo, once a day on the first week, and then for 7 consecutive weeks

DRUG

Placebo

Smilon® tablet 15mg mg/day or placebo, once a day on the first week, and then for 7 consecutive weeks

Trial Locations (1)

Nang Kuang Pharmaceutical Co., LTD, Tainan City